Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TIME Trial - Phase II Randomized Controlled Trial of Time-of-Day Specified Immunotherapy for Advanced Melanoma

NCT07155317 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT07155317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TIME Trial - Phase II Randomized Controlled Trial of Time-of-Day Specified Immunotherapy for Advanced Melanoma
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
October 29, 2025
Completion date
December 31, 2027
Enrollment
99 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced acral melanoma, advanced cutaneous melanoma, advanced mucosal melanoma, clinical stage iv cutaneous melanoma ajcc v8, metastatic acral melanoma, metastatic cutaneous melanoma, metastatic mucosal melanoma, unresectable acral melanoma, unresectable cutaneous melanoma, unresectable mucosal melanoma